Ilika plc Q&A with Dr Tom McColm at Baden Hill (LON:IKA)

Ilika Plc

Ilika plc (LON:IKA) is the topic of conversation when Baden Hill’s Partner and Equity Specialist Dr Tom McColm caught up with DirectorsTalk for an exclusive interview.

Q1: We’ve just seen that Ilika has published final results which were looking pretty good, where do you see the company’s first OEM licencing deal coming from?

A1: Yes, it’s a good question, it’s the thing that everyone’s looking for. I actually think it’ll be from one of the more specialised small scale Stereax applications and even though it was their latest and most recent product launch, the M50, this very very small millimetre scale device.

I think it will come for that product in the medical device application area because it’s such a high value add and there isn’t really any other batteries that can perform those sort of functions.

So, if I was a betting man, I’d say it’ll be an M50 application and what it definitely won’t be will be the big goliath cells in EV, I think that’s still a long way off.

Q2: So, what should investors be looking out for news flow wise over the next 12 months?

A2: Obviously, the one that I mentioned earlier, is we’re looking for this first big OEM licencing deal, it does seem like they’re getting closer and closer in a number of areas so that one will be a bit of a game changer.

Also, an important area is the relationship that they have with Semefab on the manufacturing side, information on that will be interesting, how that’s going, how that scale-up’s going because without that, the whole business model won’t work.

So, big first OEM licencing deal and good progress on the manufacturing partnership with Semefab.

Q3: Finally, what’s your view on the overall global battery market going forward?

A3: I think it’s just going to absolutely going to get massive. There’s two huge global megatrends at the moment, you’ve got the decarbonisation of energy and you’ve got the electrification of transport, both of those require vast amounts of storage.

Alongside that, you’ve still got the usual markets, consumer electronics markets, mobile phones etc. so I think there’s going to be a huge growth in the volume of batteries produced over the next 10/20 years.

Ilika plc is a pioneer in solid state battery technology. Ilika’s Stereax® state batteries include miniaturised products for powering wireless sensors in applications ranging from hostile industrial environments to medical implants.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika builds the manufacturing path for Goliath solid-state batteries

Ilika is building the manufacturing and licensing pathway needed to move its Goliath solid-state battery technology towards larger-scale commercial production.

Ilika: Stereax revenue growth and Goliath opportunities ahead

Morphose Capital Partners’ Dr Tom McColm discusses Ilika’s FY26 results, the outlook for Stereax commercial revenues, progress with Goliath and potential opportunities in automotive, defence and e-bikes.

Ilika CEO highlights Stereax revenue growth and Goliath defence interest

Ilika CEO Graeme Purdy discusses Stereax product revenue, planned M300 battery deliveries, Goliath 10Ah development, EV market trends and rising demand from the defence sector.

Ilika plc reaches a commercial turning point as new markets emerge for Stereax and Goliath (video)

Dr Tom McColm of Morphose Capital Partners explains why the company may be approaching an important commercial inflection point.

Ilika plc: Stereax Revenue Arrives as Goliath Draws Defence Interest (video)

Ilika plc CEO Graeme Purdy outlines how Stereax has started generating product-related revenue, why M300 battery deliveries remain on track and how Goliath’s 10Ah prototype is opening new opportunities in defence and sovereign battery supply.

Ilika builds commercial momentum across Stereax and Goliath batteries

Ilika Plc reports annual results for the year ended 30 April 2026, highlighting progress on its Stereax medical battery line and Goliath large-format batteries for EV, defence and consumer applications. The company began Stereax production and deliveries, shipped larger Goliath prototypes, secured further grant funding and raised £5 million post-period to accelerate commercialisation.

Search